Apollomics (APLM) Cash on Hand per Share

Corporate emblem and logo of Apollomics Inc. (APLM)

This cash per share chart demonstrates the liquidity of Apollomics, Inc. (APLM), where the latest mark stands at 0.35. Apollomics, Inc. (APLM) is focusing on launching webreltinib in the US and Chinese markets for the therapy of solid tumors. The company delegates the production of candidates to external CDMO centers, while conducting research in its own hubs. High patent requirements and rigorous FDA tests ensure robust intellectual property protection.

Cash per Share: Apollomics (APLM) for 02/21/2024 - 11/20/2026

Analytical breakdowns for Apollomics, Inc.

- stock quotes and analyst forecast:
- cash position and cash flow details:
General company analysis:Apollomics - APLM
Signature product of apollomicsinc.com

During periods of market volatility, it is critical for investors to assess an asset's intrinsic resilience. The possession of unique patents for c-Met inhibitors and the successful navigation of stringent FDA filters ensure the long-term competitiveness of Apollomics, Inc. (APLM). This metric is calculated as the ratio of net liquidity to the number of shares, determining the actual value of a single share in cash equivalents. The cash per share trend for the issuer on GURU.Markets visualizes the pace of reserve accumulation. A rising indicator reduces investment risks, bringing the market price closer to its fundamental basis.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com